Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2013; 19(18): 2793-2798
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2793
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2793
Table 2 Liver fibrosis with paired assessment at baseline vs the end of follow-up
Baseline | End of follow-up | ||||
Patients | METAVIR score | Corresponding value of LS (21) (kPa) | Mean value (range) of LS (kPa) | Mean follow-up (yr) | Patients with fibrosis regression |
1 | F0 | < 6 | 5.9 | 10.6 | 0 |
18 | F1 | 6.5 ± 1.1 | 5.4 (2.8-6.3) | 9.48 | 13 |
6 | F2 | 7.3 ± 1.4 | 6.2 (4.0-8.8) | 6.02 | 4 |
0 | F3 | 10.2 ± 1.9 | - | - | - |
1 | F4 | 15 ± 4.1 | 6.8 | 8.3 | 1 |
1 | Clinical cirrhosis | 10.3 | 19.9 | 1 | 0 |
- Citation: Morisco F, Granata R, Stroffolini T, Guarino M, Donnarumma L, Gaeta L, Loperto I, Gentile I, Auriemma F, Caporaso N. Sustained virological response: A milestone in the treatment of chronic hepatitis C. World J Gastroenterol 2013; 19(18): 2793-2798
- URL: https://www.wjgnet.com/1007-9327/full/v19/i18/2793.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i18.2793